ClinicalTrials.Veeva

Menu

A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use (PRAISE)

R

Radboud University Medical Center

Status

Enrolling

Conditions

Agitation,Psychomotor

Treatments

Other: Multicomponent intervention program

Study type

Interventional

Funder types

Other

Identifiers

NCT05783505
2022-16133

Details and patient eligibility

About

Despite deleterious effects, physical restraints are still commonly used in (expected to become) agitated patients in Dutch ICUs (20-25%). This study aims to determine the effectiveness of a person-centered multicomponent intervention (MCI) program consisting of non-pharmacological interventions combined with goal directed light sedation using dexmedetomidine compared to the old standard of care including physical restraints in (expected to become) agitated adult ICU patients.

Full description

Applying physical restraints (PR) has detrimental short- and long-term effects on patients and is increasingly seen as inhumane and outdated. Nonetheless, PR are still used in approximately 20-25% of all patients during their intensive care unit (ICU) stay in the Netherlands. The aim of this study is to determine the effectiveness of a person-centered multicomponent intervention (MCI) program consisting of non-pharmacological interventions combined with goal directed light sedation using dexmedetomidine compared to the old standard of care including physical restraints on short- and long-term outcomes and healthcare costs in (expected to become) agitated adult ICU patients.

Enrollment

480 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult ICU patients (aged ≥18) with an expected ICU stay of >24 hours
  • Patients who are (expected to become) agitated within the first 14 days of their ICU admission

Exclusion criteria

  • Contra indication for dexmedetomidine use (i.e., AV-block grade 2 or 3 unless a pacemaker is present, uncontrolled hypotension, acute cerebrovascular condition or known/suspected hypersensitivity);
  • Neurological patients with an (expected risk of) increased intracranial pressure;
  • An intoxication as a result of drug abuse (e.g., ethanol, γ-Hydroxybutyrate, opioids, benzodiazepines);
  • Support with Extracorporeal Membrane Oxygenation (ECMO);
  • Difficult airway (e.g., a Cormack and Lehane laryngoscopy grade 4 view or a tumor causing airway obstruction);
  • A high risk of physical aggression towards healthcare professionals;
  • No consent for long term follow up in the MONITOR-IC study;
  • Not able to read or understand the Dutch language and no relatives able to assist;
  • Enrolment in other sedation studies.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

480 participants in 2 patient groups

Treatment group
Experimental group
Description:
Multicomponent intervention program
Treatment:
Other: Multicomponent intervention program
Control group
No Intervention group
Description:
Standard care

Trial contacts and locations

5

Loading...

Central trial contact

Rens Kooken, MSc; Bram Tilburgs, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems